{
    "Trade/Device Name(s)": [
        "Dimension Enzymatic Creatinine (ECRE) Flex Reagent Cartridge",
        "Dimension\u00ae ECRE Flex\u00ae Reagent Cartridge",
        "Model DF270"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K073055",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003261"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFY"
    ],
    "Summary Letter Date": "January 3, 2008",
    "Summary Letter Received Date": "October 30, 2007",
    "Submission Date": "October 29, 2007",
    "Regulation Number(s)": [
        "21CFR862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension\u00ae Clinical Chemistry System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic method",
        "Bichromatic end point"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Enzymatic Creatinine (ECRE) Flex Reagent Cartridge for quantitative creatinine measurement using enzymatic method on Dimension\u00ae system",
    "Indications for Use Summary": "Quantitative measurement of creatinine in human serum, plasma, and urine to aid in diagnosis and treatment of renal diseases, monitor renal dialysis, and calculate other urine analytes",
    "fda_folder": "Clinical Chemistry"
}